Research has demonstrated heightened levels of IL-1β and IL-18 in the cerebrospinal fluid, brain tissue, and plasma of individuals affected by CNS infections, brain injuries, Alzheimer’s disease (AD), and multiple sclerosis (MS) (110). The gene discussed is IL18; the disease is Alzheimer disease.